1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CIPLA LTD.

Cipla Ltd.

NSE: CIPLA | BSE: 500087

Mid-range Performer
Download real time

1508.65 16.05 (1.08%)

1.6M NSE+BSE Volume

NSE 18 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
28S
3W
3O
2T
121,840.8

Market Cap

High in industry
24.4

PE TTM

Below industry Median
0.7

PEG TTM

PEG TTM is less than 1
4.3

Price to Book

Above industry Median
0.5

Beta 1Year

Very Low volatility


Board Meetings - Cipla Ltd.

The latest board meeting for Cipla Ltd. took place on 28 Jan 2025, for the purpose of Quarterly Results

Share
Ex-date Purpose Notes
28 Jan 2025 Quarterly Results -
29 Oct 2024 Quarterly Results -
26 Jul 2024 Quarterly Results -
10 May 2024 Audited Results & Final Dividend -
22 Jan 2024 Quarterly Results (Revised)
27 Oct 2023 Quarterly Results -
26 Jul 2023 Quarterly Results -
12 May 2023 Audited Results & Final Dividend -
25 Jan 2023 Quarterly Results -
04 Nov 2022 Quarterly Results -
29 Jul 2022 Quarterly Results -
10 May 2022 Audited Results & Dividend -
25 Jan 2022 Quarterly Results -
26 Oct 2021 Quarterly Results -
05 Aug 2021 Quarterly Results -
14 May 2021 Audited Results & Dividend -
29 Jan 2021 Quarterly Results -
06 Nov 2020 Quarterly Results -
07 Aug 2020 Quarterly Results -
15 May 2020 Audited Results & Others Inter-alia to Obtain an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities.
12 Mar 2020 Interim Dividend -
05 Feb 2020 Quarterly Results -
06 Nov 2019 Quarterly Results -
07 Aug 2019 Quarterly Results -
22 May 2019 Others inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities.
06 Feb 2019 Quarterly Results -
05 Nov 2018 Quarterly Results -
08 Aug 2018 Quarterly Results -
22 May 2018 Audited Results, Dividend & Others Inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities.
07 Feb 2018 Quarterly Results -
07 Nov 2017 Quarterly Results -
11 Aug 2017 Quarterly Results -
25 May 2017 Audited Results & Dividend -
08 Feb 2017 Quarterly Results -
19 Dec 2016 Issue of Equity Shares -
09 Nov 2016 Quarterly Results -
12 Aug 2016 Quarterly Results -
08 Jun 2016 Appointment of CFO -
24 May 2016 Audited Results & Dividend Recommended the appointment of Walker Chandiok & Co LLP, Chartered Accountants, as statutory auditors of the Company.
10 Feb 2016 Quarterly Results -
05 Nov 2015 Quarterly Results Re-appointed Mr. S. Radhakrishnan as a Whole-time Director for a term of two years with effect from November 12, 2015.
14 Aug 2015 Quarterly Results -
09 Jul 2015 Appointment of Directors -
29 May 2015 Audited Results & Dividend -
12 Feb 2015 Quarterly Results -
13 Nov 2014 Quarterly Results -
14 Aug 2014 Quarterly Results -
29 May 2014 Audited Results & Dividend -
12 Feb 2014 Quarterly Results -
13 Nov 2013 Quarterly Results -
09 Aug 2013 Quarterly Results -
29 May 2013 Audited Results & Dividend -
06 Feb 2013 Quarterly Results -
05 Nov 2012 Quarterly Results -
31 Jul 2012 Quarterly Results -
07 Jun 2012 Audited Results & Dividend -
10 May 2012 Quarterly Results -
13 Feb 2012 Quarterly Results -
14 Nov 2011 Quarterly Results -
05 Aug 2011 Quarterly Results -
29 Jun 2011 Audited Results & Dividend -
05 May 2011 Quarterly Results -
04 Feb 2011 Quarterly Results -
11 Nov 2010 Quarterly Results -
25 Aug 2010 Special Interim Dividend & Others To consider special interim dividend for the FY 2010-2011 & to approve the acquisition of Meditab Specialities Pvt. Ltd. for an aggregate consideration of Rs. 133.35 Crs.
13 Aug 2010 Quarterly Results -
15 Jun 2010 Audited Results, Dividend & Others For acquisition of 40% stake in a biotech Co. based in India through subscription of fresh Shares & 25% stake in a biotech Co. in Hong Kong through subscription of fresh Shares of the Company.
07 May 2010 Quarterly Results & Others For acquisition of two manufacturing facilities which hitherto were manufacturing formulations and bulk drugs / intermediates exclusively for Cipla Ltd. for an aggregate consideration of Rs. 82.02 Cr.
28 Jan 2010 Quarterly Results -
28 Oct 2009 Quarterly Results -
29 Jul 2009 Quarterly Results & Others To raise funds upto Rs 1500 Crs by further issue of securities in domestic / international markets through various instruments including equity shares / warrants with NCD's under QIPs / FCCBs & etc.
15 Jul 2009 Audited Results & Dividend -
24 Apr 2009 Quarterly Results -
22 Jan 2009 Quarterly Results -
22 Oct 2008 Quarterly Results -
18 Jul 2008 Audited, Quarterly Results & Dividend -
25 Apr 2008 Quarterly Results -
24 Jan 2008 Quarterly Results -
24 Oct 2007 Quarterly Results -
20 Jul 2007 Audited Results, Dividend & Qtr Results -
26 Apr 2007 Quarterly Results -
23 Jan 2007 Quarterly Results -
20 Oct 2006 Quarterly Results -
21 Jul 2006 Accounts, Dividend & Qtr Results -
25 Apr 2006 Quarterly Results -
11 Feb 2006 Bonus Issue & Issue of securities Increase in the limit of investment by Foreign Institutional Investors into the paid-up capital / securities of the Company.
24 Jan 2006 Quarterly Results -
27 Oct 2005 Quarterly Results -
25 Jul 2005 Accounts, Dividend & Quarterly Results -
26 Apr 2005 Quarterly Results -
18 Jan 2005 Quarterly Results -
26 Oct 2004 Quarterly Results -
23 Jul 2004 Quarterly Results & Dividend -
21 Apr 2004 Quarterly Results -
23 Mar 2004 Stock Split -
30 Jan 2004 Quarterly Results -
31 Oct 2003 Quarterly Results -
28 Jul 2003 Dividend & Quarterly Results -
25 Apr 2003 Quarterly Results -
18 Jan 2003 Quarterly Results -